Constitution 

The Westmead Institute for Medical Research Constitution is available here.

Board

The Board of The Westmead Institute for Medical Research is comprised of 11 directors, led by Chair, Mr Philip Chronican. It includes appointees of the University of Sydney, the NSW Government, the Westmead Institute for Medical Research Foundation and the Westmead Hospital Foundation.

The Board is responsible for oversight of the policies, strategic direction and management of the Institute.

 

Philip Chronican (Chair)

Philip is an independent director of the Westmead Institute Board of Directors.

He is a non-executive director of the National Australia Bank, the Bank of New Zealand and Chairman of the NSW Treasury Corporation.  He is also a director of both the Banking and Finance Oath and the Juvenile Diabetes Research Foundation.

In his executive career he held senior executive roles in the banking industry across Australia and New Zealand in a career that spanned over 35 years. Roles included CEO Australia for ANZ and Group Executive Institutional Banking and Chief Financial Officer for Westpac Banking Corporation..

Stephen Garton

Professor Stephen Garton is a non-executive director appointed by the University of Sydney.

Experience and expertise

Stephen Garton is Professor of History and Provost and Deputy Vice-Chancellor at the University of Sydney. He is the author or co-author of six books (one forthcoming) and over sixty articles and chapters. He is a Fellow of the Australian Academy of the Humanities, the Academy of Social Sciences in Australia and the Royal Australian Historical Society. In 2003 he was awarded a Commonwealth Centenary Medal for services to Australian History.

He has been a member of the Editorial Board of the Australian Dictionary of Biography (1995-) , the Australian Research Council Advisory Committee (2011-2014) , the ARC Laureate Fellowships Committee (2010-13), NSW Government Centenary of Anzac Advisory Committee (2013-), and a member of the Board of the Westmead Millennium Institute (2011-13 and now the Westmead Institute of Medical Research 2016-), Board of the United States Studies Centre (2009-), and Council of the Australian Academy of the Humanities (2006-8). He is also  an expert assessor for the National Cultural Heritage Committee and a member of the validation panel for the Draft Citizenship Test Resource Book. Recently he was a member of the Australian Council of Learned Academies committee, Securing Australia’s Future Report 13, "Reviewing  the Australian Research Training System”. 

Qualifications

BA (Macquarie), MCom, PhD (UNSW)

 

Anthony Cunningham AO

Tony is an executive director of the Board.

Experience and expertise

Professor Tony Cunningham AO is Executive Director of the Westmead Institute for Medical Research and Director of the Centre for Virus Research. He is also Professor of Research Medicine and Sub-Dean (Research) Sydney Medical School, Westmead, the University of Sydney and Director, Australian Centre for HIV and Hepatitis Virology Research (ACH2).

He trained in infectious diseases, clinical virology and virology research at the University of Melbourne and as a postdoctoral fellow at Stanford University. His major research interests are in HIV and Herpes Simplex Virus biology and immunology, especially in relation to the development of vaccines and microbicides.

He has also published numerous original and review articles on epidemiology, antiviral therapy and vaccines for Herpes Simplex and Varicella/Zoster viruses, has participated in numerous international roundtables and often consults for global pharma on these topics.

He has published more than 280 primary refereed scientific articles and 70 invited reviews or chapters in various journals or books and has been cited more than 10,000 times.

In 2010, Tony was awarded an Officer in the Order of Australia for “service to medicine, particularly in the field of viral research and through the development and leadership of medical and biomedical research”.

Qualifications

MD, FRACP, FRCPA, FASM, FAHMS

Read more

Susan Young

Susan is a non-executive director and Chair of the Board's Human Resources and Remuneration Committee.

Experience and expertise

Ms Susan Young has extensive experience in business, finance, consulting and governance having retired as a Partner of Spencer Stuart at the end of 2010.  Her executive search career was preceded by a corporate career with Lend Lease Corporation where she served as President of SITEL Asia Pacific and as CEO of SITEL Australia, both joint ventures between Lend Lease and SITEL Inc. of the USA, a leading global provider of customer experience management and business process outsourcing.   She also previously served as CFO of Lend Lease Corporate Services, a subsidiary of Lend Lease and as Director of Lend Lease IT+T Investments. Susan also worked for many years in corporate and investment banking in the USA and Australia for Citigroup, Wardley Australia, First National and GATX Capital Corporation where she specialised in structured finance and cross border leasing.

Susan is currently running her own executive coaching, mentoring, leadership and executive assessment business, Young Executive Services.   She is also a non-executive director of, and serves as Chair of, ClearView Life Nominees Pty Ltd, a subsidiary of ClearView Wealth Limited, an Australia financial services company offering a comprehensive range of investment, life insurance, superannuation products and financial advice. She is also a Governor of WWF Australia, having served on its board as a non-executive director for eight years and she previously served on the board of the Australia Council of Businesswomen.

Qualifications

BA (Hons), MA, FGIA, FCIS and MAICD

Bill Ketelbey

Dr Bill Ketelbey is a non-executive director.

Experience and expertise 

Dr Bill Ketelbey is a highly experienced healthcare, pharmaceutical and biotech sector professional, with more than 30 years’ experience, including most recently as CEO and Managing Director for the ASX listed biotechnology company, Actinogen Medical (ASX:ACW). Actinogen Medical is developing innovative treatments for Alzheimer’s disease and the cognitive impairment associated with neurogenerative and metabolic diseases. Prior to joining Actinogen Medical, Dr Ketelbey was an independent consultant, focusing on the Healthcare and Pharmaceutical industries in the APAC region and held a number of senior positions at Pfizer, including Regional Vice-President of Medical Affairs at Pfizer for Australia/New Zealand, Japan, Canada and Korea, Senior Vice-President/Senior Medical Director for Pfizer Japan and Country Medical Director for Pfizer ANZ.

Dr Ketelbey has a solid track record of product development over his years in the industry leading to the successful registration and commercialisation of numerous market leading medicines across a broad range of therapeutic areas.

Qualifications

Dr Ketelbey is a medical graduate from the University of the Witwatersrand, South Africa, a Fellow of the Faculty of Pharmaceutical Physicians from the Royal College of Physicians in the UK, has an MBA from Macquarie Graduate School of Management, Australia and is a Graduate of the Australian Institute of Company Directors

Michael Rose AM

Michael is a lawyer by background and the former Chief Executive Partner of Allens, one of Australia’s leading law firms.
Since leaving the legal profession Michael has served on the Boards of a number of Government, arts and not-for-profit organisations. He is currently Chairman of the Committee for Sydney, ChildFund Alliance and the Institute for Global Development at the University of New South Wales.
Michael is active in Indigenous Affairs, having been a member of the Referendum Council on Constitutional Recognition and Chairman of the Indigenous Engagement Task Force of the Business Council of Australia.
Michael has advisory roles at KPMG and UNSW and is a Fellow of the Australian Institute of Company Directors.
 
Experience
Board Roles
  • Chair, The Committee for Sydney – since 2015 (board member since 2013).
  • Chair, UNSW Institute for Global Development – since 2017
  • Chair, ChildFund Alliance – since 2011 (board member since 2006).
 
Current Advisory Roles
  • Special Advisor, KPMG – since 2017
  • Senior University Advisory, UNSW – since 2018
 
Other Governance Experience
  • Former Member, Referendum Council on Constitutional Recognition (Department of Prime Minister and Cabinet).
  • Former Member, Empowered Communities Advisory Board (Department of Prime Minister and Cabinet).
  • Member, NSW Arts and Culture Advisory Board – since 2017.
  • Chair, Sydney Living Museums (History Houses Trust of NSW) – 2010-2018.
  • Chair, ChildFund Australia – 2007-2011 (Director 2005-2017).
  • Deputy Chair – Aurora Education Foundation – 2014-2017.
  • Chair, Indigenous Engagement Task Force, Business Council of Australia – 2012-2018.
 
Executive and Professional Experience
A partner of Allens for 21 years, including sixteen years in senior leadership and management roles:
  • Chief Executive Partner – 2007-2015.
  • Executive Partner – Dispute Resolution – 2004-2007.
  • Staff Partner (responsible for People & Development) – 1999-2004.
  • Member of the Allens Board 1996-1998 and 2007-2015.
Prior to becoming a partner, worked as a lawyer in Allens officers in Sydney, New York and Hong Kong.
 
Qualifications/Memberships
Arts/Law degree – UNSW 1985.
Fellow of the Australian Institute of Company Directors.
Appointed a Member of the Order of Australia in 2016 for services to Indigenous Communities and the Legal Profession.

Julia Strelitz

Julia is a Non-Executive Director.

Julia is a Partner at PricewaterhouseCoopers whose experience is in providing financial services within the healthcare sector. She has worked with both public and private sector healthcare providers across Federal, State and hospitals effecting financial and operational improvements, providing financial analysis, productivity reviews and program evaluations.

Qualifications

Bachelor of Commerce, University of Witwatersrand, South Africa

Bachelor of Accounting, University of Witwatersrand, South Africa

Member of the Institute of Chartered Accounts in Australia (ICAA).

Special responsibilities

Julia is Chair of the Audit and Risk Committee.
 

Robyn Ward AM

Professor Robyn Ward AM FAHM represents the University of Sydney on the Board.

Professor Robyn Ward AM FAHM joined the University of Sydney in July 2018 as the inaugural Executive Dean of the Faculty of Medicine and Health. She was the former Deputy Vice-Chancellor (Research) and Executive Dean (Acting) of the Faculty of Medicine of the University of Queensland.
 
Professor Ward is an academic leader, cancer researcher and medical oncologist. She chairs the Commonwealth Medical Services Advisory Committee (MSAC), and serves on the Council and Executive of the Australian Academy of Health and Medical Sciences. In 2013 she was made Member of the Order of Australia (AM) for significant service to medical research and patient care in the field of oncology.

Graeme Loy

Mr Graeme Loy represents the Western Sydney Local Health District (WSLHD).

Over the last 12 years Graeme has held a number of executive roles, including Chief Executive for NSLHD. His knowledge of both clinical and corporate services includes a strong focus on system performance through healthy relationships.
 
Graeme has accumulated significant experience in all aspects of leadership in both the public and private sectors. He takes great pride being able to deliver highly complex clinical services through high performing teams.
 
His breadth of knowledge spans facility, district and statewide environments and enables him to couple strategic direction with the broader improvement and research goals, including ensuring optimal provision of safe, high quality and timely clinical services in concert with the needs of the community and the health system.
 
With patients as his principle focus Graeme strives to support NSW Health to deliver high quality care and brings a simple motto to each discussion – “What if it was your mum?”

Ivan Power

Mr Ivan Power represents The Westead Institute for Medical Research Foundation (WIMR Foundation). 

Ivan has extensive experience in financial markets and investment management.  He has spent over twenty years at Macquarie Group in a variety of senior roles in Sydney and London, currently leading Portfolio & Performance for Macquarie Group.  He previously worked at KPMG in Sydney.

Ivan is actively involved in various community initiatives, being Chair of Opportunity Child, a Director of the Westmead Institute for Medical Research (WIMR) and Chair of the WIMR Foundation.  He was the founding Chair of Businesses for Islington Giving (BIG) during his time in London.

Ivan is a qualified Chartered Accountant (Australia), holds a Masters in Applied Finance from Macquarie University and Bachelor of Accounting from the University of Technology, Sydney, is a Sloan Fellow from London Business School and a certified organisational coach through IECL Sydney.  He lives in Sydney with his partner and four children.

John Dakin

Mr John Dakin represents the Westmead Hospital Foundation.

John Dakin is a financial, administrative and operations professional with over 30 years experience in senior management roles generally in large complex organisations. His main emphasis throughout his career has been to ensure delivery of efficient, cost effective systems to support and enhance the overall business operation.
 
John was responsible for a number of major projects including project directing construction of two major research buildings, a large scale animal research facility, leading the sale of a merchant bank to Macquarie Bank, purchasing two major private hospital groups and the relocation of a major medical research institute into Garvan.